# Pediatric Autologous Bone Marrow Mononuclear Cells for Severe Traumatic Brain Injury

> **NCT01851083** · PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 47 (actual)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **BIOLOGICAL:** autologous bone marrow mononuclear cells
- **OTHER:** Placebo Infusion

## Key facts

- **NCT ID:** NCT01851083
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2020-09-16
- **Final completion:** 2020-10-12
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2020-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01851083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01851083, "Pediatric Autologous Bone Marrow Mononuclear Cells for Severe Traumatic Brain Injury". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01851083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*